Evaluating the Rockwood Clinical Frailty Score in patients with cardiogenic shock

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the prognostic value of the Rockwood Clinical Frailty Score in patients experiencing cardiogenic shock. It focuses on adult patients hospitalized in an Intensive Care Unit from January 2014 to September 2024, utilizing existing data to evaluate the effectiveness of this frailty score in predicting patient outcomes. The study seeks to improve the stratification of cardiogenic shock severity, which is crucial for timely and effective management. By comparing the Rockwood score with existing prognostic tools, the study aims to identify a more efficient method for assessing patient risk at the bedside.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patient (≥18 years)
* Patient with cardiogenic shock according to ESC 2021 definition
* Patient hospitalized from January 1, 2014 to September 1, 2024 in an Intensive Care Unit
* Patients who do not object to the re-use of their data for the purposes of this research.

Criteria Exclusion:

* Patient having expressed his opposition to the re-use of his data for scientific research purposes.
* Subject under court protection.
* Subject under guardianship or curatorship.

Where it's running

• Service de Médecine Intensive - Réanimation - CHU de Strasbourg - France
  Strasbourg, France Recruiting

Study contacts

• Study coordinator: Hamid MERDJI, MD
• Email: hamid.merdji@chru-strasbourg.fr
• Phone: 33 3 69 55 11 23

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Factors Influencing Outcomes in ECMO and Impella Patients

  This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.

  Recruiting Gottsegen National Cardiovascular Institute · Budapest · NCT07885618

• Evaluating a noninvasive tissue sensor to detect cardiogenic shock earlier in heart patients

  This pilot, noninvasive study tests whether the NIRSense wearable can help detect deterioration in adults with cardiogenic shock risk due to heart attack or heart failure.

  Recruiting NIRSense Inc. · Weston, Florida · NCT07825363

• Safety and Efficacy of an Extracorporeal Ventricular Assist System for Cardiogenic Shock

  This study tests whether an extracorporeal ventricular assist device can safely provide short-term heart support and help patients with cardiogenic shock or trouble weaning from bypass.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07769528

• Left Ventricular Support and Advanced Monitoring in AMI–Cardiogenic Shock: Immediate Impella Use and PAC/Monitoring vs Standard Care

  In adults with heart attack-related cardiogenic shock, this trial tests whether using an Impella left ventricular assist device and/or protocolized pulmonary artery catheter monitoring improves survival compared with standard care.

  Recruiting Leipzig Heart Science gGmbH · Leipzig, Saxony · NCT07762560

• CRP Apheresis for infarct-related cardiogenic shock

  This study tests whether selectively removing C-reactive protein with apheresis, in addition to standard care, helps people with cardiogenic shock after a heart attack.

  Recruiting Leipzig Heart Science gGmbH · Leipzig, Saxony · NCT07687017

• Compare two ventilator modes in adults with cardiac ICU needs and invasive ventilation

  This pilot tests whether volume-controlled versus pressure-controlled ventilation can be safely used in adults with heart disease and respiratory failure who need invasive ventilation.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07656259

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.